Carisma Therapeutics Inc. financial data

Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
Location
3675 Market Street, Suite 200, Philadelphia, Pennsylvania
State of incorporation
Pennsylvania
Fiscal year end
December 31
Former names
Sesen Bio, Inc. (to 3/6/2023), Eleven Biotherapeutics, Inc. (to 5/16/2018)
Latest financial report
10-Q - Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 602 % +18.6%
Debt-to-equity 115 % +62.9%
Return On Equity -216 % -311%
Return On Assets -80.6 % -63.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41.5 M shares -79.6%
Common Stock, Shares, Outstanding 41.5 M shares +3.2%
Entity Public Float 276 M USD +70.6%
Common Stock, Value, Issued 41 K USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 40.9 M shares +220%
Weighted Average Number of Shares Outstanding, Diluted 40.9 M shares +220%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.1 M USD +24%
Research and Development Expense 74.9 M USD +16.2%
General and Administrative Expense 25.4 M USD +51.7%
Operating Income (Loss) -85.3 M USD -23.6%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -81.2 M USD -8.93%
Earnings Per Share, Basic -1.12 USD/shares +95.6%
Earnings Per Share, Diluted -1.12 USD/shares +95.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 56.5 M USD -9.98%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 56.5 M USD -59.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 61 M USD -57.8%
Property, Plant and Equipment, Net 7.38 M USD
Operating Lease, Right-of-Use Asset 5.15 M USD +47.4%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 73.8 M USD -52.7%
Accounts Payable, Current 2.17 M USD -53.1%
Employee-related Liabilities, Current 881 K USD
Accrued Liabilities, Current 4.73 M USD -53.6%
Liabilities, Current 13.1 M USD -38.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 2.76 M USD +191%
Other Liabilities, Noncurrent 1.13 M USD -40.4%
Liabilities 62.9 M USD -10.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -264 M USD -44.4%
Stockholders' Equity Attributable to Parent 26.5 M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 10.9 M USD -87.3%
Liabilities and Equity 73.8 M USD -52.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.4 M USD +12.2%
Net Cash Provided by (Used in) Financing Activities 1.35 M USD -98%
Net Cash Provided by (Used in) Investing Activities -17 K USD +99.5%
Common Stock, Shares Authorized 350 M shares +250%
Common Stock, Shares, Issued 41.5 M shares +3.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.15 M USD -86.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 56.5 M USD -10%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50 K USD +11.1%
Deferred Tax Assets, Valuation Allowance 134 M USD +172%
Deferred Tax Assets, Gross 135 M USD +165%
Operating Lease, Liability 5.23 M USD +47.6%
Payments to Acquire Property, Plant, and Equipment 17 K USD -87.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81.4 M USD +4.21%
Lessee, Operating Lease, Liability, to be Paid 5.91 M USD +46.7%
Property, Plant and Equipment, Gross 105 K USD -89.6%
Operating Lease, Liability, Current 2.47 M USD -4.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 427 K USD +95%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.63 M USD +1134%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 673 K USD +39.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 232 K USD +2.66%
Deferred Tax Assets, Operating Loss Carryforwards 72.7 M USD +169%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 240 K USD +3%
Operating Lease, Payments 1.46 M USD +1.04%
Additional Paid in Capital 275 M USD +2.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.17 M USD -34.8%
Share-based Payment Arrangement, Expense 3.11 M USD +589%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares